FDA Inspection 1170505 — AXIS Clinicals Limited
The FDA completed an inspection of AXIS Clinicals Limited on May 5, 2022 in Ahmedabad. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 5, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Ahmedabad (India)
Additional Details
Clinical BA/BE